French nationwide registry of colorectal endoscopic submucosal dissection at expert centers
Official title: French Colorectal ESD Cohort in Experts Centers
Run by University Hospital, Limoges · NCT04592003 · Data updated 2026-11-12
We will collect outcomes from patients referred for colorectal endoscopic submucosal dissection (ESD) at expert French centers to see how safe and effective ESD is for removing large superficial colorectal lesions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | University Hospital, Limoges Academic / other |
| Locations | 25 sites (Amiens and 24 other locations) |
| Status | Recruiting |
| Started | January 1, 2020 |
| Main results expected | January 1, 2026 |
| Study ends | January 1, 2026 |
| Registry record updated | September 15, 2025 |
| Trial ID | NCT04592003 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults referred for colorectal ESD for large superficial neoplastic or pre-neoplastic colorectal lesions.
✕Probably not a fit
Patients with invasive colorectal cancer requiring surgery, those not referred for or who decline ESD, or patients with contraindications to endoscopic resection are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter observational cohort will enroll all patients referred for colorectal ESD at participating French expert centers and prospectively record procedural, histological, safety, and follow-up outcomes. Data collected will include en bloc resection and recurrence rates, perforation and bleeding complications, procedure duration, and need for repeat interventions or surgery. The project aims to provide large-scale, real-world evidence on safety, effectiveness, and practice patterns of colorectal ESD across France compared with published benchmarks for wide-field EMR. As an observational registry, it will describe outcomes and variation in practice rather than provide randomized comparisons.
Why it matters
Potential benefit: If successful, this registry could clarify the real-world safety and effectiveness of colorectal ESD and inform treatment choices for large superficial colorectal lesions.
How similar studies have gone: Japanese series have shown high en bloc resection rates and low recurrence with ESD, but prospective comparative data in Western populations are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients addressed for a colorectal ESD Exclusion Criteria: Opposition notified in the context of a non-opposition form after reading the information notice
Where it's running
-
CHU d'Amiens
Amiens, France Recruiting -
Clinique de l'Anjou
Angers, France Recruiting -
CHU de Besançon
Besançon, France Recruiting -
CHU de Bordeaux
Bordeaux, France Recruiting -
CHRU de Brest
Brest, France Recruiting -
CHU de Dijon
Dijon, France Recruiting
Show 19 more locations
-
CHU de Limoges
Limoges, France Recruiting -
Hopital Edouard Herriot
Lyon, France Recruiting -
Hôpital Jean Mermoz
Lyon, France Recruiting -
Hôpital Européen
Marseille, France Recruiting -
CHU de Montpellier
Montpellier, France Recruiting -
CHU de Nancy
Nancy, France Recruiting -
Clinique Jules Vernes
Nantes, France Recruiting -
CHU de Nantes
Nantes, France Recruiting -
CHU de Nice
Nice, France Recruiting -
CHU de Nîmes
Nîmes, France Recruiting -
Hôpital St Antoine
Paris, France Recruiting -
Hôpital Cochin - APHP
Paris, France Recruiting -
Hôpital St Joseph
Paris, France Recruiting -
Hôpital Européen Georges Pompidou-APHP
Paris, France Recruiting -
CHU de Rennes
Rennes, France Recruiting -
CHU de Rouen
Rouen, France Recruiting -
Clinique Santé Atlantique
Saint-Herblain, France Recruiting -
CHU de Strasbourg
Strasbourg, France Recruiting -
CHU de Toulouse
Toulouse, France Recruiting
Study contacts
- Principal investigator: Jérémie Jacques, Pr — Service d'Hépato-Gastro-Entérologie et Nutrition du CHU de LIMOGES
- Study coordinator: Jérémie Jacques, Pr
- Email: jeremie.jacques@chu-limoges.fr
- Phone: 05 55 05 87 72
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Building Connections: improving cancer screening, weight management, and mental health for adults in vulnerable communities
This program will try to improve cancer screening, weight management, and mental health care for adults served by community clinics in Massachusetts.
-
GripTract GI Endoscopic Tissue Manipulator for complex colon polypectomies
This study tests the GripTract device to see if it is safer and more effective than the current method for removing complex colon polyps in adults.
-
Blood screening test for colorectal cancer in adults
This project will test whether the blood protein TFPI-1 can tell apart adults aged 50–75 who have colorectal cancer from people the same age with a normal colonoscopy.
-
Using blood tests to monitor colorectal cancer relapse and chemotherapy effectiveness
This study is testing a blood test that looks for cancer DNA to see if it can help track cancer coming back and how well chemotherapy works for people who had early-stage colorectal cancer.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.